A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Malignant Glioma

This study has been completed.
Sponsor:
Information provided by:
Angiochem Inc
ClinicalTrials.gov Identifier:
NCT00539344
First received: October 2, 2007
Last updated: June 3, 2010
Last verified: June 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2010
  Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)